The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Travel Sickness Drugs Market Research Report 2024
Synopsis
Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Travel Sickness Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Travel Sickness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travel Sickness Drugs.
Report Scope
The Travel Sickness Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travel Sickness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travel Sickness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Viatris
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Travel Sickness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Travel Sickness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Travel Sickness Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Travel Sickness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travel Sickness Drugs.
Report Scope
The Travel Sickness Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travel Sickness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travel Sickness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Viatris
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Travel Sickness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Travel Sickness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Travel Sickness Drugs Market Overview
1.1 Product Overview and Scope of Travel Sickness Drugs
1.2 Travel Sickness Drugs Segment by Type
1.2.1 Global Travel Sickness Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Travel Sickness Drugs Segment by Application
1.3.1 Global Travel Sickness Drugs Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Travel Sickness Drugs Market Size Estimates and Forecasts
1.4.1 Global Travel Sickness Drugs Revenue 2019-2030
1.4.2 Global Travel Sickness Drugs Sales 2019-2030
1.4.3 Global Travel Sickness Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Travel Sickness Drugs Market Competition by Manufacturers
2.1 Global Travel Sickness Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Travel Sickness Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Travel Sickness Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Travel Sickness Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Travel Sickness Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Travel Sickness Drugs, Product Type & Application
2.7 Travel Sickness Drugs Market Competitive Situation and Trends
2.7.1 Travel Sickness Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Travel Sickness Drugs Players Market Share by Revenue
2.7.3 Global Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travel Sickness Drugs Retrospective Market Scenario by Region
3.1 Global Travel Sickness Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Travel Sickness Drugs Global Travel Sickness Drugs Sales by Region: 2019-2030
3.2.1 Global Travel Sickness Drugs Sales by Region: 2019-2024
3.2.2 Global Travel Sickness Drugs Sales by Region: 2025-2030
3.3 Global Travel Sickness Drugs Global Travel Sickness Drugs Revenue by Region: 2019-2030
3.3.1 Global Travel Sickness Drugs Revenue by Region: 2019-2024
3.3.2 Global Travel Sickness Drugs Revenue by Region: 2025-2030
3.4 North America Travel Sickness Drugs Market Facts & Figures by Country
3.4.1 North America Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Travel Sickness Drugs Sales by Country (2019-2030)
3.4.3 North America Travel Sickness Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Travel Sickness Drugs Market Facts & Figures by Country
3.5.1 Europe Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Travel Sickness Drugs Sales by Country (2019-2030)
3.5.3 Europe Travel Sickness Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Travel Sickness Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Travel Sickness Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Travel Sickness Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Travel Sickness Drugs Market Facts & Figures by Country
3.7.1 Latin America Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Travel Sickness Drugs Sales by Country (2019-2030)
3.7.3 Latin America Travel Sickness Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Travel Sickness Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Travel Sickness Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Travel Sickness Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Travel Sickness Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Travel Sickness Drugs Sales by Type (2019-2030)
4.1.1 Global Travel Sickness Drugs Sales by Type (2019-2024)
4.1.2 Global Travel Sickness Drugs Sales by Type (2025-2030)
4.1.3 Global Travel Sickness Drugs Sales Market Share by Type (2019-2030)
4.2 Global Travel Sickness Drugs Revenue by Type (2019-2030)
4.2.1 Global Travel Sickness Drugs Revenue by Type (2019-2024)
4.2.2 Global Travel Sickness Drugs Revenue by Type (2025-2030)
4.2.3 Global Travel Sickness Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Travel Sickness Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Travel Sickness Drugs Sales by Application (2019-2030)
5.1.1 Global Travel Sickness Drugs Sales by Application (2019-2024)
5.1.2 Global Travel Sickness Drugs Sales by Application (2025-2030)
5.1.3 Global Travel Sickness Drugs Sales Market Share by Application (2019-2030)
5.2 Global Travel Sickness Drugs Revenue by Application (2019-2030)
5.2.1 Global Travel Sickness Drugs Revenue by Application (2019-2024)
5.2.2 Global Travel Sickness Drugs Revenue by Application (2025-2030)
5.2.3 Global Travel Sickness Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Travel Sickness Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Travel Sickness Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Prestige Brands
6.2.1 Prestige Brands Corporation Information
6.2.2 Prestige Brands Description and Business Overview
6.2.3 Prestige Brands Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Prestige Brands Travel Sickness Drugs Product Portfolio
6.2.5 Prestige Brands Recent Developments/Updates
6.3 WellSpring Pharmaceutical Corporation
6.3.1 WellSpring Pharmaceutical Corporation Corporation Information
6.3.2 WellSpring Pharmaceutical Corporation Description and Business Overview
6.3.3 WellSpring Pharmaceutical Corporation Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 WellSpring Pharmaceutical Corporation Travel Sickness Drugs Product Portfolio
6.3.5 WellSpring Pharmaceutical Corporation Recent Developments/Updates
6.4 Baxter International
6.4.1 Baxter International Corporation Information
6.4.2 Baxter International Description and Business Overview
6.4.3 Baxter International Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter International Travel Sickness Drugs Product Portfolio
6.4.5 Baxter International Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Corporation Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Viatris Travel Sickness Drugs Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sandoz Travel Sickness Drugs Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Travel Sickness Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Myungmoon Pharm
6.8.1 Myungmoon Pharm Corporation Information
6.8.2 Myungmoon Pharm Description and Business Overview
6.8.3 Myungmoon Pharm Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Myungmoon Pharm Travel Sickness Drugs Product Portfolio
6.8.5 Myungmoon Pharm Recent Developments/Updates
6.9 Caleb Pharmaceuticals
6.9.1 Caleb Pharmaceuticals Corporation Information
6.9.2 Caleb Pharmaceuticals Description and Business Overview
6.9.3 Caleb Pharmaceuticals Travel Sickness Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Caleb Pharmaceuticals Travel Sickness Drugs Product Portfolio
6.9.5 Caleb Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Travel Sickness Drugs Industry Chain Analysis
7.2 Travel Sickness Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Travel Sickness Drugs Production Mode & Process
7.4 Travel Sickness Drugs Sales and Marketing
7.4.1 Travel Sickness Drugs Sales Channels
7.4.2 Travel Sickness Drugs Distributors
7.5 Travel Sickness Drugs Customers
8 Travel Sickness Drugs Market Dynamics
8.1 Travel Sickness Drugs Industry Trends
8.2 Travel Sickness Drugs Market Drivers
8.3 Travel Sickness Drugs Market Challenges
8.4 Travel Sickness Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
